Publications by authors named "H K Ooi"
Adult-Onset Myoclonus in a Large Urban Inpatient Setting: A Retrospective Cohort Study.
Tremor Other Hyperkinet Mov (N Y)
January 2025
Background: Myoclonus is a hyperkinetic movement with various attributable etiologies, semiologies, and treatment outcomes. To our knowledge, few studies investigated adult-onset myoclonus in an inpatient setting.
Methods: We retrospectively reviewed charts of adult inpatients with myoclonus at New York Presbyterian Brooklyn Methodist Hospital between 2011 and 2021.
Background: Predicted heart mass ratio (PHMr) has become the standard donor-recipient size matching method in heart transplantation. While utilization of small PHMr hearts is associated with increased one-year mortality, the underlying mechanisms and time horizon of mortality remain uncertain.
Methods: A single institution analysis of isolated heart transplant recipients (01/2019-7/2022) was performed (N=334).
Article Synopsis
- Diuresis is crucial for treating patients with acute decompensated heart failure (ADHF) to relieve fluid buildup, but there's no one-size-fits-all diuretic strategy that has proven to be the best.
- Current research highlights the connection between urine sodium levels and patient outcomes, suggesting that monitoring urine chemistry could help tailor diuretic treatments.
- The review aims to consolidate existing studies on diuretic management, identify what we still don't know, and outline ongoing clinical trials that explore urine sodium-guided diuresis in ADHF management.
Advanced glycation end-products (AGEs) form through non-enzymatic glycation of various proteins. Optic nerve degeneration is a frequent complication of diabetes, and retinal AGE accumulation is strongly linked to the development of diabetic retinopathy. Type 2 diabetes mellitus is a major risk factor for Alzheimer's disease (AD), with patients often exhibiting optic axon degeneration in the nerve fiber layer.
View Article and Find Full Text PDFBackground: Piperacillin/tazobactam (PIPC/TAZ), which is a combination of a beta-lactam/beta-lactamase inhibitor, often causes liver enzyme abnormalities. The albumin-bilirubin (ALBI) score is a simple index that uses the serum albumin and total bilirubin levels for estimating hepatic functional reserve. Although patients with low hepatic reserve may be at high risk for drug-induced liver enzyme abnormalities, the relationship between PIPC/TAZ-induced abnormal liver enzymes levels and the ALBI score remains unknown.
View Article and Find Full Text PDF